Institutional investors purchased a net $340.0 thousand shares of STEM during the quarter ended March 2016 and now own 8.71% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BARRY INVESTMENT ADVISORS LLC Sold 860.00 shares of StemCells Inc
CREATIVE PLANNING, INC. Sold 5.4 Thousand shares of StemCells Inc